Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 96

    Fund Diversion Case: SEBI restricts Transgene Biotek, 6 others from securities market

    Fund Diversion Case: SEBI restricts Transgene Biotek, 6 others from securities market

    Medical Dialogues Bureau2 Sept 2019 10:00 AM IST
    Besides, Transgene will continue the measures to recall the outstanding amount of USD 38.5 million and bring the money back into its bank account in...
    NovaLead Pharma topical drug Galnobax for Diabetic Foot Ulcer proceeds for phase 3 trial

    NovaLead Pharma topical drug Galnobax for Diabetic Foot Ulcer proceeds for phase 3 trial

    Farhat Nasim2 Sept 2019 9:45 AM IST
    "Development of Galnobax and the clinical trials are also supported by Department of Biotechnology under the BIPP program," said Novalead...
    Amgen challenges Alexion Pharma blood disorder treatment Soliris in US patent court

    Amgen challenges Alexion Pharma blood disorder treatment Soliris in US patent court

    Medical Dialogues Bureau2 Sept 2019 9:30 AM IST
    The IPR is seeking to invalidate new patents covering the composition of the main ingredient of Soliris, eculizumab, its formulation, and its use to...
    Kyowa Kirin gets USFDA approval for Nourianz tablets to treat adults with Parkinsons disease

    Kyowa Kirin gets USFDA approval for Nourianz tablets to treat adults with Parkinsons disease

    Medical Dialogues Bureau2 Sept 2019 9:00 AM IST
    New Delhi: Kyowa Kirin, Inc. recently won the U.S. Food and Drug Administration approval for Nourianz (istradefylline) tablets as an add-on treatment...
    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Farhat Nasim1 Sept 2019 2:33 PM IST
    New Delhi: In a major relief to Natco, the Delhi High Court has lifted a ban on Natco Pharma from manufacturing fresh stock of on-small cell lung...
    Violation of Market Norms: SEBI imposes Rs 1.15 crore fine on Pharma Company

    Violation of Market Norms: SEBI imposes Rs 1.15 crore fine on Pharma Company

    Medical Dialogues Bureau1 Sept 2019 11:00 AM IST
    During the investigation, SEBI revealed that the loan paid by Vintage was secured by pledge agreement between Syncom and EURAM Bank.New Delhi: Markets...
    Biocon gets 4 observations, Complete Response Letter from USFDA for Insulin Glargine

    Biocon gets 4 observations, Complete Response Letter from USFDA for Insulin Glargine

    Farhat Nasim1 Sept 2019 10:15 AM IST
    The United Food and Drug Administration (USFDA) has also issued four observations after cGMP inspection of one of Biocon's biologics drug product...
    5 pc GDP should act as wake-up call for Government to act more: Kiran Mazumdar Shaw

    5 pc GDP should act as wake-up call for Government to act more: Kiran Mazumdar Shaw

    Farhat Nasim1 Sept 2019 10:00 AM IST
    Kiran Mazumdar Shaw, who heads the south-headquartered Biocon, said the economic growth data clearly suggests a fall in consumption which needs to be...
    Sandoz recalls Losartan Potassium, Ezetimibe drug bottles in US over packaging issue

    Sandoz recalls Losartan Potassium, Ezetimibe drug bottles in US over packaging issue

    Medical Dialogues Bureau1 Sept 2019 9:37 AM IST
    New Delhi: Sandoz Inc. recently announced a voluntary recall and corrective action notice for particular lots of Losartan Potassium and Ezetimibe...
    USFDA expands investigation on generic drug impurities in US

    USFDA expands investigation on generic drug impurities in US

    Medical Dialogues Bureau1 Sept 2019 9:35 AM IST
    Since last summer, the USFDA has been conducting a major investigation to address the presence of certain impurities that could cause cancer in ARBs...
    AstraZeneca lupus drug Anifrolumab shows encouraging sign in final stage

    AstraZeneca lupus drug Anifrolumab shows encouraging sign in final stage

    Medical Dialogues Bureau1 Sept 2019 9:30 AM IST
    AstraZeneca said Anifrolumab under the TULIP 2 program helped patients with systemic lupus erythematosus, commonly known as SLE.U.S: AstraZeneca Plc...
    AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business

    AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business

    Farhat Nasim31 Aug 2019 2:35 PM IST
    New Delhi: A lobby of 8.5 lakh chemists across the country is planning to boycott the products manufactured by Cipla if the company enters the e...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok